SafeScript turns four: What have we learnt? Three GPs reflect on the real-time monitoring system for high-risk medications, the benefits and what could be improved.
New overdose report a ‘wake-up call’ Nearly 1800 drug-induced deaths were recorded in 2021 – equivalent to five per day – a new UNSW report has found.
‘Many roads to change’: The therapeutic alliance for AOD use A newly published paper in AJGP builds on the RACGP’s AOD Education Program to present a ‘universally applicable’ approach for GPs.
Success of GP-led AOD program shown in report The RACGP’s alcohol and other drugs education program has received a ringing endorsement.
Queensland pill testing move ‘will save lives’ The Queensland state government is set to introduce pill testing for the first time, a move that has been backed by the RACGP.
Addiction medicine conference hailed as ‘unique’ event IMiA 2023 aimed to promote quality healthcare and generated ‘a great deal of respect for the work GPs achieve in this space’.
Support for proposed expansion of drug diversion program The Queensland Government has introduced legislation that would see people receive a warning for first time minor drug possession.
Trial aims to improve therapy access for insomnia The pilot is designed to better support GPs with management, referral pathways and non-drug interventions for patients with insomnia.
In Practice: Temporary telehealth exemption Until at least 31 March, high-risk COVID patients seeking PCR testing will not need to have an established clinical relationship to access telehealth.
Study weighs up impact of different drug dosages for men and women New research that has found women are not just ‘smaller versions of men’ could help to reduce adverse reactions to medication.